Form 4 for VNRX VOLITIONRX LTD
Accepted 2022-12-13 00:00:00 ET · period of report 2022-12-12 · accession 0001477932-22-009249 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-13 | 2022-12-12 | VNRX | Butera Salvatore Thomas | CEO - Volition Veterinary | P - Purchase | $2.09 | +4,350 | 46.4K | +10% | +$9,092 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-12 | P | A | 4,350 | $2.09 | 46,350 | D | — | — | (F1) These shares of common stock are jointly owned by the reporting person and his spouse. |